Triacetin Identified as Key Antiadipogenic Agent in Bauhinia
2026-07-06
The referenced study provides the first integrated pharmacological and chemical analysis of Bauhinia divaricata L., establishing triacetin as a principal compound with significant antiadipogenic effects in vitro. This advances understanding of natural lipid regulators and highlights potential for translational research in obesity therapeutics.
VDR Activation Mitigates Cisplatin-Induced AKI via Ferroptos
2026-07-05
This study establishes that vitamin D receptor (VDR) activation can attenuate cisplatin-induced acute kidney injury (AKI) by inhibiting ferroptosis. Mechanistically, VDR regulates GPX4 expression, reducing lipid peroxidation and ferroptotic cell death in renal models, offering new insight into protective strategies against nephrotoxic injury.
GPNMB-Based Model Improves Immunotherapy Prediction in ESCC
2026-07-04
This study introduces a multimodal model leveraging circulating GPNMB and CAF-Epi niche features to predict immunotherapy response in esophageal squamous cell carcinoma (ESCC). The research demonstrates how integrating spatial and circulating biomarkers with clinical-pathological data enhances patient stratification and informs precision immunotherapy.
Panoramic Opto-Electrical Mapping of Mouse Hearts: Technical
2026-07-03
The reference study introduces a panoramic opto-electrical measurement and stimulation (POEMS) system, enabling simultaneous, high-resolution electrical and optical mapping of mouse hearts. This innovation provides a powerful platform for dissecting cardiac electrophysiology in transgenic models, offering new insights into heart function and arrhythmia mechanisms.
Applied Use of (-)-Norepinephrine (+)-bitartrate in Cardiova
2026-07-03
(-)-Norepinephrine (+)-bitartrate sets the standard for reliable induction and modulation in cardiovascular and adrenergic signaling studies. This article breaks down actionable workflows, advanced applications, and troubleshooting strategies to maximize reproducibility—backed by recent clinical data and competitive benchmarking.
Applied Ceftolozane Sulfate: In Vitro and In Vivo Assay Mast
2026-07-02
Ceftolozane sulfate unlocks high-reproducibility antibacterial assays, excelling against multidrug-resistant Pseudomonas aeruginosa and non-carbapenemase-producing Enterobacterales. This guide blends experimental workflow optimization, troubleshooting, and comparative insights to maximize research impact using APExBIO’s Ceftolozane sulfate.
THZ1 (SKU A8882): Optimizing CDK7 Inhibition in Cancer Resea
2026-07-02
Discover how THZ1 (SKU A8882), a potent covalent CDK7 inhibitor, addresses key reproducibility and sensitivity challenges in cancer biology workflows. This article presents scenario-driven guidance and data-backed solutions for researchers performing transcription regulation, cell viability, and apoptosis assays, emphasizing the scientific rigor and practical advantages of THZ1 in T-ALL and broader oncology research.
Open-Tubular CEC Enables Precise β2-AR Binding Constant Anal
2026-07-01
A recent study introduces an open-tubular capillary electrochromatography (CEC) method with a part-coating column to quantify binding constants between β2-adrenergic receptors and several drugs, including norepinephrine bitartrate. This approach reduces protein consumption, improves throughput, and provides robust affinity data, informing both drug screening and mechanistic research in adrenergic receptor signaling.
VNERi Index Enhances Septic Shock Severity Assessment with N
2026-07-01
Goury et al. introduce the VNERi index—a composite of diastolic arterial pressure, norepinephrine dose, and heart rate—which outperforms traditional hemodynamic measures in predicting outcomes for early septic shock. This metric may refine bedside decision-making and vasopressor therapy personalization.
Tacalcitol Monohydrate: Applied Workflows for NGF and Cancer
2026-06-30
Tacalcitol monohydrate stands out as a synthetic analog of vitamin D3 that enables precise induction of nerve growth factor (NGF) and synergy with chemotherapeutics in both dermatology and oncology models. This article details hands-on experimental workflows, troubleshooting, and optimization strategies to maximize reproducibility and biological insight.
Broad-Spectrum Bivalent mRNA Vaccine RQ3025 Counters SARS-Co
2026-06-30
The referenced study introduces RQ3025, a bivalent mRNA vaccine engineered to target multiple SARS-CoV-2 variants by integrating prevalent spike protein mutations. In preclinical models, RQ3025 induced broad neutralizing antibodies and robust Th1-biased cellular immunity, demonstrating protective efficacy and safety, with implications for next-generation COVID-19 vaccine development.
Disulfiram: Dopamine β-Hydroxylase Inhibitor in Cancer Resea
2026-06-29
Disulfiram’s dual role as a dopamine β-hydroxylase inhibitor and proteasome modulator is reshaping cancer research workflows, particularly for synthetic lethality studies in APC-deficient tumors. This article presents protocol-driven strategies, troubleshooting insights, and emerging applications, with practical guidance rooted in recent breakthrough findings.
Obeticholic Acid: FXR Agonism Redefining Liver Fibrosis Mode
2026-06-29
Explore how Obeticholic Acid, a potent FXR agonist, advances liver fibrosis research through precision gene modulation and cross-talk with immunometabolic pathways. This article reveals new experimental strategies and comparative insights for MASLD models.
Applied Use of CNQX for Dissecting Glutamatergic Pathways
2026-06-28
CNQX empowers precise inhibition of AMPA and kainate receptors for circuit-level mapping and neuropharmacological dissection. Its selectivity and robust performance make it essential for advanced neuroscience research and troubleshooting neural excitatory transmission.
Aloin Isoforms Selectively Inhibit SARS-CoV-2 PLpro In Vitro
2026-06-27
The reference study demonstrates that only aloin A and B—among various oral rinse actives—selectively inhibit both proteolytic and deubiquitinating activities of the SARS-CoV-2 papain-like protease (PLpro) in vitro. These findings clarify ingredient-specific antiviral mechanisms, guide assay development for oral infection research, and highlight the need for careful mechanistic evaluation in translational workflows.
505 records 16/34 page Previous Next First page 上5页 1617181920 下5页 Last page